Journal
NATURE REVIEWS CANCER
Volume 14, Issue 3, Pages 173-186Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3680
Keywords
-
Categories
Funding
- The Cancer Research Society
- Carcinoid NeuroEndocrine Tumour Society of Canada
Ask authors/readers for more resources
The RET receptor tyrosine kinase is crucial for normal development but also contributes to pathologies that reflect both the loss and the gain of RET function. Activation of RET occurs via oncogenic mutations in familial and sporadic cancers - most notably, those of the thyroid and the lung. RET has also recently been implicated in the progression of breast and pancreatic tumours, among others, which makes it an attractive target for small-molecule kinase inhibitors as therapeutics. However, the complex roles of RET in homeostasis and survival of neural lineages and in tumour-associated inflammation might also suggest potential long-term pitfalls of broadly targeting RET.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available